Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,128 | 169 | 90.5% |
| Travel and Lodging | $537.43 | 1 | 7.9% |
| Entertainment | $107.25 | 1 | 1.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| SUN PHARMACEUTICAL INDUSTRIES INC. | $912.34 | 35 | $0 (2024) |
| Bausch & Lomb, a division of Bausch Health US, LLC | $795.21 | 8 | $0 (2021) |
| Novartis Pharmaceuticals Corporation | $692.06 | 26 | $0 (2023) |
| Bausch & Lomb Americas Inc. | $675.00 | 15 | $0 (2024) |
| Alcon Vision LLC | $630.85 | 3 | $0 (2020) |
| Oyster Point Pharma, Inc. | $340.54 | 13 | $0 (2024) |
| Aerie Pharmaceuticals, Inc. | $307.51 | 7 | $0 (2021) |
| Johnson & Johnson Vision Care, Inc. | $290.51 | 5 | $0 (2023) |
| Optos, Inc. | $255.47 | 4 | $0 (2023) |
| Alcon Laboratories Inc | $248.72 | 2 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $760.82 | 29 | Bausch & Lomb Americas Inc. ($289.95) |
| 2023 | $1,186 | 29 | Bausch & Lomb Americas Inc. ($260.06) |
| 2022 | $1,018 | 28 | Sun Pharmaceutical Industries Inc. ($182.22) |
| 2021 | $565.47 | 16 | SUN PHARMACEUTICAL INDUSTRIES INC. ($145.88) |
| 2020 | $1,289 | 23 | Alcon Vision LLC ($610.77) |
| 2019 | $807.91 | 18 | Bausch & Lomb, a division of Bausch Health US, LLC ($262.87) |
| 2018 | $842.92 | 16 | Alcon Laboratories Inc ($248.72) |
| 2017 | $302.89 | 12 | Allergan Inc. ($115.00) |
All Payment Transactions
171 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | Bausch & Lomb Americas Inc. | VYZULTA (Drug) | Food and Beverage | In-kind items and services | $16.85 | General |
| Category: Ophthalmology | ||||||
| 12/20/2024 | RxSight Inc | RXSIGHT CONTACT LENS (Device), RXSIGHT INJECTOR CARTRIDGE, RXSIGHT INJECTOR HANDPIECE | Food and Beverage | In-kind items and services | $17.39 | General |
| Category: OPHTHALMOLOGY | ||||||
| 12/04/2024 | Thea Pharma Inc. | IYUZEH (Drug) | Food and Beverage | In-kind items and services | $20.51 | General |
| Category: OPHTHALMOLOGY | ||||||
| 12/03/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug) | Food and Beverage | In-kind items and services | $18.35 | General |
| Category: Ophthalmology | ||||||
| 11/06/2024 | Dompe US, Inc. | OXERVATE (Drug) | Food and Beverage | Cash or cash equivalent | $67.65 | General |
| Category: SOLUTION/ DROPS | ||||||
| 11/06/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug) | Food and Beverage | In-kind items and services | $26.29 | General |
| Category: Ophthalmology | ||||||
| 10/16/2024 | Bausch & Lomb Americas Inc. | INFUSE (Device) | Food and Beverage | In-kind items and services | $107.72 | General |
| Category: Ophthalmology | ||||||
| 10/03/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $20.40 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 09/24/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $26.66 | General |
| Category: Inflammation/Rare Disease | ||||||
| 09/20/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $25.52 | General |
| Category: Ophthalmology | ||||||
| 09/16/2024 | Bausch & Lomb Americas Inc. | VYZULTA (Drug) | Food and Beverage | In-kind items and services | $14.99 | General |
| Category: Ophthalmology | ||||||
| 08/29/2024 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Food and Beverage | In-kind items and services | $21.82 | General |
| Category: Dry eyes | ||||||
| 08/21/2024 | Dompe US, Inc. | OXERVATE (Drug) | Food and Beverage | In-kind items and services | $22.65 | General |
| Category: SOLUTION/ DROPS | ||||||
| 07/24/2024 | Bausch & Lomb Americas Inc. | VYZULTA (Drug) | Food and Beverage | In-kind items and services | $11.83 | General |
| Category: Ophthalmology | ||||||
| 07/09/2024 | Bausch & Lomb Americas Inc. | VYZULTA (Drug) | Food and Beverage | In-kind items and services | $15.69 | General |
| Category: Ophthalmology | ||||||
| 06/25/2024 | Bausch & Lomb Americas Inc. | VYZULTA (Drug) | Food and Beverage | In-kind items and services | $14.53 | General |
| Category: Ophthalmology | ||||||
| 06/12/2024 | Bausch & Lomb Americas Inc. | XIIDRA (Drug), MIEBO | Food and Beverage | In-kind items and services | $24.26 | General |
| Category: Ophthalmology | ||||||
| 06/01/2024 | Glaukos Corporation | iStent infinite Trabecular Micro-Bypass System Model iS3 (Device) | Food and Beverage | Cash or cash equivalent | $48.74 | General |
| Category: Glaucoma | ||||||
| 05/31/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $26.08 | General |
| Category: Inflammation/Rare Disease | ||||||
| 05/20/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $18.08 | General |
| Category: Inflammation/Rare Disease | ||||||
| 05/13/2024 | Bausch & Lomb Americas Inc. | VYZULTA (Drug) | Food and Beverage | In-kind items and services | $12.58 | General |
| Category: Ophthalmology | ||||||
| 05/13/2024 | Bausch & Lomb Americas Inc. | VYZULTA (Drug) | Food and Beverage | In-kind items and services | $8.36 | General |
| Category: Ophthalmology | ||||||
| 04/05/2024 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Food and Beverage | In-kind items and services | $25.58 | General |
| Category: Dry eyes | ||||||
| 03/29/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug) | Food and Beverage | In-kind items and services | $19.86 | General |
| Category: Ophthalmology | ||||||
| 03/07/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $19.26 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 620 | 766 | $118,693 | $52,559 |
| 2022 | 7 | 907 | 1,025 | $151,271 | $61,047 |
| 2021 | 9 | 889 | 1,005 | $149,113 | $63,356 |
| 2020 | 9 | 806 | 914 | $131,244 | $49,453 |
All Medicare Procedures & Services
33 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 92014 | Established patient complete exam of visual system | Office | 2023 | 344 | 469 | $81,266 | $41,165 | 50.7% |
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 56 | 59 | $7,129 | $3,260 | 45.7% |
| 92134 | Imaging of retina | Office | 2023 | 85 | 100 | $13,200 | $2,914 | 22.1% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 22 | 22 | $4,160 | $2,049 | 49.3% |
| 92133 | Imaging of optic nerve | Office | 2023 | 45 | 47 | $6,204 | $1,173 | 18.9% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 26 | 27 | $3,336 | $986.22 | 29.6% |
| 92250 | Photography of the retina | Office | 2023 | 22 | 22 | $2,438 | $627.53 | 25.7% |
| 92020 | Exam of the internal drainage system of eye | Office | 2023 | 20 | 20 | $960.00 | $383.52 | 39.9% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 339 | 394 | $67,910 | $30,874 | 45.5% |
| 92012 | Established patient problem focused exam of visual system | Office | 2022 | 178 | 223 | $27,539 | $13,969 | 50.7% |
| 92004 | New patient complete exam of visual system | Office | 2022 | 66 | 66 | $12,480 | $6,581 | 52.7% |
| 92083 | Exam of visual field with extended testing | Office | 2022 | 82 | 89 | $11,520 | $3,597 | 31.2% |
| 92134 | Imaging of retina | Office | 2022 | 117 | 126 | $16,399 | $3,092 | 18.9% |
| 92250 | Photography of the retina | Office | 2022 | 57 | 57 | $6,183 | $1,510 | 24.4% |
| 92133 | Imaging of optic nerve | Office | 2022 | 68 | 70 | $9,240 | $1,424 | 15.4% |
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | Office | 2021 | 319 | 367 | $63,382 | $30,647 | 48.4% |
| 92012 | Eye and medical examination for diagnosis and treatment, established patient | Office | 2021 | 145 | 196 | $24,452 | $12,352 | 50.5% |
| 92004 | Eye and medical examination for diagnosis and treatment, new patient, 1 or more visits | Office | 2021 | 93 | 93 | $17,664 | $10,100 | 57.2% |
| 92134 | Diagnostic imaging of retina | Office | 2021 | 149 | 163 | $21,439 | $4,537 | 21.2% |
| 92133 | Diagnostic imaging of optic nerve of eye | Office | 2021 | 78 | 79 | $10,428 | $1,954 | 18.7% |
| 92250 | Photography of the retina | Office | 2021 | 50 | 51 | $5,604 | $1,561 | 27.9% |
| 92083 | Measurement of field of vision during daylight conditions, extended examination | Office | 2021 | 29 | 30 | $3,960 | $1,212 | 30.6% |
| 92002 | Eye and medical examination for diagnosis and treatment, new patient | Office | 2021 | 13 | 13 | $1,482 | $897.00 | 60.5% |
| 76514 | Ultrasound of corneal structure and measurement | Office | 2021 | 13 | 13 | $702.00 | $95.80 | 13.6% |
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | Office | 2020 | 244 | 276 | $47,582 | $23,272 | 48.9% |
About Dr. Michael Wang, OD
Dr. Michael Wang, OD is a Optometrist healthcare provider based in Elk Grove, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/09/2005. The National Provider Identifier (NPI) number assigned to this provider is 1104820950.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Wang, OD has received a total of $6,772 in payments from pharmaceutical and medical device companies, with $760.82 received in 2024. These payments were reported across 171 transactions from 31 companies. The most common payment nature is "Food and Beverage" ($6,128).
As a Medicare-enrolled provider, Wang has provided services to 3,222 Medicare beneficiaries, totaling 3,710 services with total Medicare billing of $226,415. Data is available for 4 years (2020–2023), covering 33 distinct procedure/service records.
Practice Information
- Specialty Optometrist
- Location Elk Grove, CA
- Active Since 06/09/2005
- Last Updated 06/17/2013
- Taxonomy Code 152W00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1104820950
Products in Payments
- DAILIES (Device) $786.15
- XIIDRA (Drug) $785.07
- INFUSE (Device) $603.11
- Cequa (Drug) $374.63
- TYRVAYA (Drug) $340.54
- BIOTRUE (Device) $331.95
- Acuvue (Device) $290.51
- CEQUA (Drug) $281.99
- Rhopressa (Drug) $269.89
- OXERVATE (Drug) $167.73
- MyDay Contact Lens (Device) $162.82
- BIOTRUE ONE DAY (Device) $141.26
- ALDEN SCLERAL ZENLENS (Device) $135.07
- VABYSMO (Drug) $122.27
- DURYSTA (Drug) $117.84
- BTOD (Device) $112.98
- PROKERA (Device) $108.25
- NFC-700 (Device) $107.25
- BromSite (bromfenac ophthalmic solution) 0.075% (Drug) $100.00
- OCT (Device) $98.82
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Optometrist Doctors in Elk Grove
Dr. Anhthu Do, O.d, O.D
Optometrist — Payments: $5,707
Thuy Ha, O.d, O.D
Optometrist — Payments: $5,225
Larry Huey, O.d, O.D
Optometrist — Payments: $4,991
Harissa Michael, O.d, O.D
Optometrist — Payments: $4,716
Dr. Viraj Shah, O.d, O.D
Optometrist — Payments: $3,949
Dr. Sharon Yurko, O.d, O.D
Optometrist — Payments: $3,620